Table 4 GRADE Evidence Profile Summarizing the Effect of TM versus Control.
Quality assessment | Summary of findings | Â | Â | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | Â | Â | Â | Â | Â | Â | Number of patients | Effect | Â | Importance | ||
Number of studies | Design | Limitations | Inconsistency | Indirectness | Imprecision | Other considerations | Telemedicine | Control | Relative (95% CI) | Absolute | Quality | Â |
HbA1c at closest point in time to end of intervention | ||||||||||||
7 | Randomised trials | Serious1 | No serious inconsistency | Serious2 | No serious imprecision | None | 243 | 242 | — | MD 0.13 lower (0.36 lower to 0.11 higher) |
LOW | Critical |
Severe Hypoglycemia | ||||||||||||
4 | Randomised trials | Serious1 | No serious inconsistency | No serious indirectness | Serious3 | None | 1/85 (1.2%) | 0/68 (0%) | OR 2.78 (0.1 to 74.7) | 0 more per 1000 (from 0 fewer to 0 more) |
LOW | Critical |
Diabetic Ketoacidosis | ||||||||||||
4 | Randomised trials | Serious1 | No serious inconsistency | No serious indirectness | Serious3 | None | 2/85 (2.4%) | 2/86 (2.3%) | OR 1.05 (0.14 to 7.8) | 1 more per 1000 (from 20 fewer to 133 more) |
LOW | Critical |
OO
OO 
OO